G. Garcia‐Manero

Decreased expression level of SH2 domain‐containing protein tyrosine phosphatase‐1 (Shp1) is associated with progression of chronic myeloid leukaemia

H M Amin, Koyu Hoshino, Hanshuo Yang et al. · The Journal of Pathology · 2007 · 45 citations

Immunology, Fusion Protein Bcr‐abl, Tumor Biology +21

14 Revised International Prognostic Scoring System (IPSS-R), developed by the International Prognostic Working Group for Prognosis in MDS (IWG-PM)

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Leukemia Research · 2011 · 26 citations

Prognostic Assessment, Prognostic Biomarkers, Prognostic Evaluation +8

Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia

Courtney D. DiNardo, Vazganush Gharibyan, Haopeng Yang et al. · American Journal of Hematology · 2013 · 23 citations · Full text

Hematological Malignancy, Chromatin, Aberrant Methylation +15

Clinical activity and safety of the histone deacetylase inhibitor MGCD0103: Results of a phase I study in patients with leukemia or myelodysplastic syndromes (MDS)

G. Garcia‐Manero, Mark D. Minden, Zeev Estrov et al. · Journal of Clinical Oncology · 2006 · 17 citations

Histone Modifications, Mixed-phenotype Acute Leukemia, Human Histone Deacetylases +20

A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome

Naval Daver, Arturo Vega-Ruiz, H Kantarjian et al. · European Journal of Cancer Care · 2013 · 16 citations · Full text